课题基金 / 基金详情

CTLA-4 (CD152)-induced signaling pathways as regulators of CD8+ T lymphocytes (B14)

CTLA-4 (CD152)-induced signaling pathways as regulators of CD8+ T lymphocytes (B14)
CTLA-4 (CD152) 诱导的信号通路作为 CD8 T 淋巴细胞的调节剂 (B14)
批准号:
163824312
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Collaborative Research Centres
财政年份:
2010
资助国家:
德国
项目状态:
已结题
起止时间:
2009-12-31 至 2020-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
为了防止免疫病理,CD8+ T细胞的分化受到抑制受体(如CTLA-4)的严格控制。项目B14与B16合作,通过iTRAQ质谱鉴定了CTLA-4下游的新型信号转导途径,将在第三个资助期进一步表征。在这方面,B14将细胞代谢的变化与T细胞功能的改变联系起来。ctla -4介导的TCF-1调控在记忆形成中的作用将在李斯特菌感染模型中与A05合作进行分析。此外,B14将与B08和B12合作,分析CTLA-4在共刺激和粘附的情况下对JAML的影响。
英文摘要
To prevent immunopathology, differentiation of CD8+ T cells is tightly controlled by inhibitory receptors such as CTLA-4. Project B14, in collaboration with B16, identified by iTRAQ mass spectrometry novel signal transduction pathways downstream of CTLA-4 that will be further characterized in the 3rd funding period. In this respect, B14 will connect changes in cellular metabolism with altered T cell functions. The role of CTLA-4-mediated TCF-1 regulation in memory formation will be analyzed in a Listeria infection model in collaboration with A05. Furthermore, B14 will analyze the impact of CTLA-4 on JAML in the context of co-stimulation and adhesion in collaboration with B08 and B12.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
FK506对肾移植受者Treg细胞负性共刺激信号分子-CD152、PD-1和BTLA的免疫耐受调节研究
  • 批准号:
    30950010
  • 项目类别:
    专项基金项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2009
  • 负责人:
    石运莹
  • 依托单位: